High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients

Inherited mutations in the BRCA1 and BRCA2 genes are the strongest genetic predictors of breast cancer and are the primary causes of familial breast/ovarian cancer syndrome. The frequency, spectrum and penetrance of mutant BRCA1/BRCA2 alleles have been determined for several populations, but little information is available for populations of African ancestry, who suffer a disproportionate burden of early onset breast cancer. We have performed complete sequence analysis of all BRCA1 and BRCA2 exons and intron–exon boundaries for 434 Nigerian breast cancer patients from the University College Hospital in Ibadan, Nigeria. In contrast to previous suggestions that BRCA1/BRCA2 mutation frequencies are low or undetectable in African American populations, we find that Nigerian breast cancer patients have an exceptionally high frequency of BRCA1 and BRCA2 mutations (7.1 and 3.9%, respectively). Sixteen different BRCA1 mutations were detected, seven of which have never been reported previously, while thirteen different BRCA2 mutations were seen, six of which were previously unreported. Thus, our data support enrichment for genetic risk factors in this relatively young cohort. To improve breast cancer outcomes, we suggest that family‐based models of risk assessment and genetic counseling coupled with interventions to reduce breast cancer risk should be broadly disseminated in Nigeria and other underserved and understudied populations.

[1]  O. Olopade,et al.  Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population , 2010, Breast Cancer Research and Treatment.

[2]  Alice S Whittemore,et al.  Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. , 2007, JAMA.

[3]  Olufunmilayo I. Olopade,et al.  Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations , 2007, Nature Reviews Cancer.

[4]  F. Couch,et al.  Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants? , 2007, Breast Cancer Research.

[5]  Fergus J Couch,et al.  A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. , 2007, American journal of human genetics.

[6]  A. Ashworth,et al.  BRCA1 dysfunction in sporadic basal-like breast cancer , 2007, Oncogene.

[7]  C. Ambrosone,et al.  Breast cancer in African-American women: differences in tumor biology from European-American women. , 2006, Cancer research.

[8]  Giske Ursin,et al.  Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. , 2006, Cancer research.

[9]  T. Walsh,et al.  Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. , 2006, JAMA.

[10]  O. Olopade,et al.  BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. , 2005, Cancer research.

[11]  L. Esserman,et al.  Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. , 2005, JAMA.

[12]  B. Haffty,et al.  Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women , 2005, Journal of Medical Genetics.

[13]  A. Richardson,et al.  BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles , 2005, Breast Cancer Research and Treatment.

[14]  L. Newman,et al.  Breast cancer in sub‐Saharan Africa: How does it relate to breast cancer in African‐American women? , 2005, Cancer.

[15]  C. Rotimi,et al.  Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients , 2005, Journal of Medical Genetics.

[16]  R. Sutphen,et al.  BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  A. Ellis.  Breast , 2002, BMJ : British Medical Journal.

[18]  O. Olopade,et al.  Racial differences in genetic factors associated with breast cancer , 2003, Cancer Metastasis Review.

[19]  C. Rotimi,et al.  Waist–hip ratio and breast cancer risk in urbanized Nigerian women , 2002, Breast Cancer Research.

[20]  K. Phillips.  Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  K Holli,et al.  Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. , 2000, Journal of the National Cancer Institute.

[22]  Csilla Szabo,et al.  The Breast Cancer Information Core: Database design, structure, and scope , 2000, Human mutation.

[23]  R. Tollenaar,et al.  Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients , 1999, British Journal of Cancer.

[24]  C. Adebamowo,et al.  Case‐controlled study of the epidemiological risk factors for breast cancer in Nigeria , 1999, The British journal of surgery.

[25]  G. Giles,et al.  The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations , 1998, Cancer.

[26]  E. Smith,et al.  Pattern of breast cancer among white-American, African-American, and nonimmigrant west-African women. , 1998, Journal of the National Medical Association.

[27]  M. Stratton,et al.  Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. , 1998, Journal of the National Cancer Institute.

[28]  H. Mefford,et al.  BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. , 1997, American journal of human genetics.

[29]  Julian Peto,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1996, Nature.

[30]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[31]  C. Redmond,et al.  Histological characteristics of breast carcinoma in blacks and whites. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[32]  J. Anim,et al.  Breast cancer in sub-Saharan African women. , 1993, African journal of medicine and medical sciences.

[33]  S. Narod,et al.  A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas , 2010, Breast Cancer Research and Treatment.

[34]  C. Adebamowo,et al.  Evidence for an ancient BRCA1 mutation in breast cancer patients of yoruban ancestry , 2008, Familial Cancer.

[35]  Dee W. West,et al.  Prevalence of Pathogenic BRCA 1 Mutation Carriers in 5 US Racial / Ethnic Groups , 2007 .

[36]  B. Trock.  Breast cancer in African American women: Epidemiology and tumor biology , 2005, Breast Cancer Research and Treatment.

[37]  L. Newman,et al.  Breast cancer in African-American women. , 2005, The oncologist.

[38]  O. Olopade,et al.  Breast cancer genetics in African Americans , 2003, Cancer.

[39]  O. Olopade,et al.  Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer , 2001, Human Genetics.

[40]  M. West,et al.  Racial differences in breast carcinoma survival , 2000, Cancer.

[41]  E. Ostrander,et al.  Mutation testing of early-onset breast cancer genes BRCA1 and BRCA2. , 1997, Genetic testing.

[42]  D. Easton,et al.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.